Sree Rayalaseema Hypo Q1 PAT at Rs 25.17 cr, up 7.5% YoY; revenue at Rs 210.95 cr
SRHHYPOLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 1.3 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sree Rayalaseema Hi-Strength Hypo posted Q1 FY27 standalone revenue from operations of Rs 210.95 crore, up 17 percent YoY from Rs 180.26 crore. Total income stood at Rs 220.83 crore. PAT rose 7.5 percent YoY to Rs 25.17 crore versus Rs 23.41 crore; EPS at Rs 14.66 versus Rs 13.64. PBT margin slipped to 15.6 percent from 16.9 percent YoY. An exceptional loss of Rs 3.50 crore came from gold futures mark-to-market. Pending UK court case over a shipment dispute was noted.
Mixed quarter: topline up 17% YoY but profit margins compressed. Exceptional gold futures loss and ongoing UK litigation weigh on sentiment.